Enterprise Products Partners CapEx decreased by 24.4% to $983.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.4%, from $1.06B to $983.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 26.1% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $622.00M | $505.00M | $417.00M | $349.00M | $382.00M | $472.00M | $761.00M | $653.00M | $780.00M | $821.00M | $1.01B | $1.05B | $1.26B | $1.17B | $1.06B | $1.06B | $1.30B | $1.96B | $1.30B | $983.00M |
| QoQ Change | — | -18.8% | -17.4% | -16.3% | +9.5% | +23.6% | +61.2% | -14.2% | +19.4% | +5.3% | +23.3% | +3.5% | +20.7% | -7.1% | -9.8% | +0.3% | +22.3% | +50.7% | -33.6% | -24.4% |
| YoY Change | — | — | — | — | -38.6% | -6.5% | +82.5% | +87.1% | +104.2% | +73.9% | +33.0% | +60.3% | +62.1% | +43.0% | +4.6% | +1.4% | +2.8% | +66.8% | +22.9% | -7.4% |